James L Vincent - Net Worth and Insider Trading

James L Vincent Net Worth

The estimated net worth of James L Vincent is at least $0 dollars as of 2024-11-13. James L Vincent is the Director of Alnylam Pharmaceuticals Inc and owns about 0 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $0. Details can be seen in James L Vincent's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James L Vincent has not made any transactions after 2010-06-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of James L Vincent

To

James L Vincent Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James L Vincent owns 1 companies in total, including Alnylam Pharmaceuticals Inc (ALNY) .

Click here to see the complete history of James L Vincent’s form 4 insider trades.

Insider Ownership Summary of James L Vincent

Ticker Comapny Transaction Date Type of Owner
ALNY Alnylam Pharmaceuticals Inc 2010-06-18 director

James L Vincent Latest Holdings Summary

James L Vincent currently owns a total of 1 stock. James L Vincent owns 0 shares of Alnylam Pharmaceuticals Inc (ALNY) as of June 18, 2010, with a value of $0.

Latest Holdings of James L Vincent

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALNY Alnylam Pharmaceuticals Inc 2010-06-18 0 268.95 0

Holding Weightings of James L Vincent


James L Vincent Form 4 Trading Tracker

According to the SEC Form 4 filings, James L Vincent has made a total of 0 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 22,100 shares on June 18, 2010, which brought James L Vincent around $336,141.

Insider Trading History of James L Vincent

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James L Vincent Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James L Vincent Ownership Network

Ownership Network List of James L Vincent

No Data

Ownership Network Relation of James L Vincent

Insider Network Chart

James L Vincent Owned Company Details

What does Alnylam Pharmaceuticals Inc do?

Who are the key executives at Alnylam Pharmaceuticals Inc?

James L Vincent is the director of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include EVP & Chief Commercial Officer Yvonne Greenstreet , EVP & Chief Commercial Officer Tolga Tanguler , and CMO & EVP Dev & Med Affairs Pushkal Garg .

Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary

Over the past 18 months, James L Vincent made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 52,531 shares made by Yvonne Greenstreet , a net sale of 10,304 shares made by Pushkal Garg , and a net sale of 5,639 shares made by Jeffrey V. Poulton .

In summary, during the past 3 months, insiders sold 15,000 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 15,000 shares. During the past 18 months, 249,128 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 249,128 shares.

Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alnylam Pharmaceuticals Inc Insider Transactions

No Available Data

James L Vincent Mailing Address

Above is the net worth, insider trading, and ownership report for James L Vincent. You might contact James L Vincent via mailing address: 7 Audubon Road, Weston Ma 02493.